Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 223

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 223
---
 noncurrent

    5,747

    8,227

    Deferred tax liability

    6,948

    8,539

    Total liabilities

    122,325

    121,382

    Commitments and contingencies (Note 9)

    Stockholders' equity

    Common stock, $0.001 par value per share; 200,000,000 shares authorized; 23,902,338 and 23,324,750 shares issued and outstanding as of December 31, 2024 and 2023, respectively

    24

    23

    Additional paid-in capital

    328,174

    320,513

    Accumulated deficit

    (152,837
    )

    (116,949
    )

    Accumulated other comprehensive income (loss)

    (1,501
    )

    1,225

    Total stockholders' equity

    173,860

    204,812

    Total liabilities and stockholders' equity
     
    $
    296,185

    $
    326,194

See accompanying notes to the consolidated financial statements.

 F-4

Inogen, Inc. 

Consolidated Statements of Comprehensive Loss 

(amounts in thousands, except share and per share amounts) 

    Years Ended December 31,

    2024

    2023

    2022

    Revenue

    Sales revenue
     
    $
    278,756

    $
    251,607

    $
    320,549

    Rental revenue

    56,949

    64,053

    56,692

    Total revenue

    335,705

    315,660

    377,241

    Cost of revenue

    Cost of sales revenue

    148,655

    158,636

    197,805

    Cost of rental revenue, including depreciation of $12,592, $12,893 and

    $11,103, respectively

    32,309

    30,325

    25,903

    Total cost of revenue

    180,964

    188,961

    223,708

    Gross profit

    Gross profit-sales revenue

    130,101

    92,971

    122,744

    Gross profit-re